NDAVAGINALCREAM
Approved
Oct 2004
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
2/8 — Basic
Drug data last refreshed 22h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Terconazole is an azole antifungal agent administered as a vaginal cream for the treatment of vaginal yeast infections. It works by disrupting fungal cell membrane synthesis through inhibition of ergosterol production. The product is a mature, off-patent antifungal with routine clinical use in gynecology.
LOE Approaching
Declining lifecycle stage with moderate competitive pressure (30) suggests consolidating team focus and transition planning for brand management.
Mechanism of Action
Pharmacologic Class:
Azole Antifungal
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
A Study to Compare Efficacy and Safety of an Ovule Containing Terconazole, Clindamycin and Fluocinolone Versus an Ovule Containing Metronidazole, Nystatin and Fluocinolone in the Treatment of Secondary Vulvar/ or Vaginal Symptoms of Infectious Vaginitis/ and Infectious Vaginosis
Started Dec 2007
160 enrolled
VaginitisInfectious Vaginosis
Career Relevance
Working on terconazole offers experience in mature product management, generic competition strategy, and OTC transition dynamics, but limited exposure to innovation or high-growth therapeutic development. Career progression will depend on successfully managing declining revenue and transitioning team focus to adjacent opportunities.
Brand Manager
Worked on TERCONAZOLE at Sandoz? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.